MOLOMICS BIOTECH SL

molomics-biotech-sl-logo

The purpose of Molomics is to discover safer small molecule therapeutics with better efficacy.

#People #Website #More

MOLOMICS BIOTECH SL

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics

Founded:
2015-01-01

Address:
Barcelona, Catalonia, Spain

Country:
Spain

Website Url:
http://www.molomics.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving


Current Employees Featured

jascha-blobel_image

Jascha Blobel
Jascha Blobel CEO @ Molomics Biotech SL
CEO
2015-01-01

Founder


jascha-blobel_image

Jascha Blobel

Official Site Inspections

http://www.molomics.com

Unable to get host informations!!!

Loading ...

More informations about "Molomics Biotech SL"

Molomics │ Drug Discovery & Development Technology - VeriSIM …

Molomics technology integrates Artificial Intelligence with Collective Human Intelligence to collaboratively design high potential drug candidates with diverse structures in real-time. Learn …See details»

Molecular Omics Home-A home for your multi-omics research …

A home for your multi-omics research alongside proteomics, genomics, transcriptomics, metabolomics, glycomics, and lipidomics research Editorial Board Chair: Robert Moritz Impact …See details»

VeriSIM Life Announces Acquisition of Molomics Biotech

Founded in 2015 in Barcelona, Catalonia, Spain, Molomics integrates AI with Human Collective Intelligence (HCI) to determine novel chemical structures with high therapeutic activity and …See details»

VeriSIM Life | AI Drug Discovery & Development

Our mission is to eliminate inaccuracy and waste when translating drug candidates to clinical trials using AI-driven, multi-disciplinary quantitative methods that predict patient outcomes. What if? …See details»

VeriSIM Life Announces Acquisition of Molomics Biotech

May 11, 2022 · Molomics is a drug discovery and development company that uses Artificial Intelligence (AI) to create more efficacious drugs with fewer side effects. The power of its …See details»

Molomics Biotech SL - Crunchbase Company Profile & Funding

Where is Molomics Biotech SL's headquarters? Molomics Biotech SL is located in Barcelona, Catalonia, Spain. Who are Molomics Biotech SL's competitors? Alternatives and possible …See details»

US company VeriSIM Life acquires start-up Molomics Biotech

May 18, 2022 · Molomics’ technology will seamlessly integrate into VeriSIM’s ‘virtual drug development engine’, BIOiSIMâ„¢, to further improve the success rates for the discovery, …See details»

Molecular Omics journal - The Royal Society of Chemistry

Molecular Omics publishes high-quality research from across the -omics sciences that provide significant new insight into important chemical or biological problems.See details»

VeriSIM Life acquires Molomics Biotech SL - Crunchbase

May 11, 2022 · Acquired Organization: Molomics Biotech SL The purpose of Molomics is to discover safer small molecule therapeutics with better efficacy. Acquiring Organization:See details»

US company VeriSIM Life acquires start-up Molomics Biotech

Molomics Biotech (www.molomics.com) is a drug discovery and development company that uses Artificial Intelligence (AI) to create more effective drugs with fewer side effects. The power of …See details»

VeriSIM Life Announces Acquisition of Molomics Biotech

May 17, 2022 · Molomics is a drug discovery and development company that uses Artificial Intelligence (AI) to create more efficacious drugs with fewer side effects. The power of its …See details»

VeriSIM Accelerating novel drugs to patients together–how …

Molomics integrates Artificial Intelligence (AI) with Human Collective Intelligence (HCI) to determine novel chemical structures with high therapeutic activity and superior …See details»

Molomics - Products, Competitors, Financials, Employees, …

Founded in 2015 in Barcelona, Catalonia, Spain, Molomics integrates AI with Human Collective Intelligence (HCI) to determine novel chemical structures with high therapeutic activity and …See details»

Call For Papers: Single cell -omics – Molecular Omics Blog

Aug 2, 2023 · We are delighted to announce a call for papers for our latest online themed collection in Molecular Omics on single cell -omics guest edited by Dr Bogdan Budnik (Wyss …See details»

RSC MO vol iss D3MO90010J 187. - RSC Publishing

Full details on how to submit material for publication in Molecular Omics are given in the Instructions for Authors (available from http://www.rsc.org/authors). Submissions should be …See details»

Molecular Omics Blog – A blog from RSC Publishing - Royal …

Sep 20, 2023 · Research in her lab focuses on developing mass spectrometry-based proteomics, metabolomics and lipidomics methods to study neuroscience questions.See details»

Call For Papers: -omics of microbiomes – Molecular Omics Blog

Aug 8, 2023 · This call for papers is open to both research and review articles. If you are interested in providing a review please contact the Editorial Office at [email protected] …See details»

Volume 19 Molecular October 2023 Omics - RSC Publishing

Jul 3, 2023 · Integrated multi-omics analyses of microbiomes have become increasingly common in recent years as the emerging omics technologies provide an unprecedented opportunity to …See details»

Call for Papers: 2021 Emerging Investigators issue

Jul 17, 2020 · We are delighted to announce the first Emerging Investigators issue in Molecular Omics ! This issue will showcase some of the best research from scientists in the early stages …See details»

Volume 17 Molecular December 2021 Omics - RSC Publishing

Emerging evidence suggests that microRNA dysregulation plays an important role in nonalcoholic steatohepatitis. Using a model of diet-induced liver disease that progresses to fibrosis and …See details»